malondialdehyde has been researched along with g(m1) ganglioside in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avrova, NF; Erin, AN; Kagan, VE; Kuznetsova, LA; Pertseva, MN; Tiurin, VA; Tiurina, IuIu | 1 |
Chen, JT; Ruan, DY; She, JQ; Tang, M; Wang, L; Wang, M; Zhu, DM | 1 |
Li, J; Liu, X; Min, L; Sui, R; Wang, Q; Yang, R | 1 |
Deng, X; Fang, X; Li, J; Li, S; Lu, Y; Xu, R; Zhang, J; Zhou, Y | 1 |
4 other study(ies) available for malondialdehyde and g(m1) ganglioside
Article | Year |
---|---|
[Participation of gangliosides in protection of beta adrenergic receptors from damaging effect induced by lipid peroxidation in synaptosome membranes].
Topics: Animals; Cerebral Cortex; G(M1) Ganglioside; In Vitro Techniques; Lipid Peroxidation; Malondialdehyde; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Spectrophotometry; Synaptosomes; Vitamin E | 1991 |
Monosialoanglioside (GM1) prevents lead-induced neurotoxicity on long-term potentiation, SOD activity, MDA levels, and intracellular calcium levels of hippocampus in rats.
Topics: Animals; Calcium; Female; G(M1) Ganglioside; Hippocampus; Lead Poisoning, Nervous System; Long-Term Potentiation; Male; Malondialdehyde; Organometallic Compounds; Rats; Rats, Wistar; Superoxide Dismutase | 2009 |
Monosialoanglioside improves memory deficits and relieves oxidative stress in the hippocampus of rat model of Alzheimer's disease.
Topics: Aldehydes; Alzheimer Disease; Animals; Disease Models, Animal; G(M1) Ganglioside; Hippocampus; Malondialdehyde; Maze Learning; Memory Disorders; Oxidative Stress; Rats; Rats, Wistar | 2013 |
The possible mechanism of Parkinson's disease progressive damage and the preventive effect of GM1 in the rat model induced by 6-hydroxydopamine.
Topics: Animals; bcl-2-Associated X Protein; Brain; Calcium; Calmodulin; Disease Progression; G(M1) Ganglioside; Glutamic Acid; Infusions, Parenteral; Male; Malondialdehyde; Mitochondria; Neuroprotective Agents; Nitric Oxide Synthase Type I; Oxidopamine; Parkinsonian Disorders; Proto-Oncogene Proteins c-bcl-2; Rats, Wistar; Trace Elements | 2014 |